316 results
8-K
EX-10.2
DMKPQ
DMK Pharmaceuticals Corp
19 Oct 23
Entry into a Material Definitive Agreement
5:07pm
to exist for or by me, this Release and Waiver and the consideration hereunder expressly are agreed to and shall constitute an accord and satisfaction
8-K
EX-10.1
7vpteqa
19 Oct 23
Entry into a Material Definitive Agreement
5:07pm
DEFC14A
a2ibo g8xr630but
12 Oct 23
Proxy in contested solicitation
4:22pm
PREC14A
xipv4a z2r0ins2eq
2 Oct 23
Preliminary proxy with contested solicitation
4:49pm
8-K
EX-10.1
317 zdcevz
29 Aug 23
Entry into a Material Definitive Agreement
4:30pm
8-K
m8b68
3 Aug 23
Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering
4:59pm
8-K
EX-10.1
9tq9sgmyba8buh yc
3 Aug 23
Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering
4:59pm
8-K
EX-99.1
xzz1h 5uvk
3 Aug 23
Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering
4:59pm
424B4
vsh11g
3 Aug 23
Prospectus supplement with pricing info
4:55pm
8-K
vq70v0 zb
24 Jul 23
Entry into a Material Definitive Agreement
4:20pm